TIS tissue therapies limited

market value

  1. 49 Posts.
    A point to consider;

    Why only one distributor?

    It would make sense to have a German distributor (or British or French)for the EU etc, an American distributor for the USA and either one of the two for "the rest of the world' , which includes Australia.

    Market penetration would be much greater, in my opinion, and in Europe I see no reason why it should not reach at least 50% of the available total. Public health services would certainly facilitate this, as a cost saving measure if nothing else.

    Depending on the Distributor's deal, that alone could take the share price to ? $9 ?. Do your own sums, this is just one of mine and not to be taken as set in stone!!

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.